Biologit: Funding, Investors & Team (Sep 2026)
Our company is in its infancy and focuses on utilizing artificial intelligence to address the challenges that come with clinical safety and pharmacovigilance. Our goal is to streamline the identification of negative drug reactions from drug development to post-market and enhance patient safety. The inaugural product we are creating is directed towards Medical Literature Monitoring (MLM), which will give medical product license holders, sponsors, patients, healthcare professionals, and scientists reliable data pertaining to the safety, effectiveness, and quality of medicinal products.
Biologit has raised $3.2M across 2 funding rounds on record, the most recent a Seed of $2.1M announced in Mar 2023.
That round is below the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Biologit Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Biologit Funding Rounds
Biologit raised $1.1M in a Seed announced in Apr 2022.
11 months later, a Seed of $2.1M was announced in Mar 2023.
Biologit Founders and Leadership Team
Contact details for the Biologit team: 1 of 1 has an email address on file.
Start 14-day free trial →Biologit Funding Compared to Other Artificial Intelligence Startups
Biologit's latest round of $2.1M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biologit in Artificial Intelligence and Dublin
Companies Similar to Biologit
Ubotica is to deploy advanced Artificial Intelligence technologies on board every satellite.
Nexus Inclusion's aim is to make sure that inclusion is taken into account at every stage of product…
Better Futures Limited is an up-and-coming machine learning company that is dedicated to providing developers…
MARC is an AI startup dedicated to real estate asset management.
AICertified provides AI skills training and certification as an edtech platform
Luna’s AI & Computer Vision solution provides real-time irrefutable confirmation to operators and cities that…
Meso is an edtech spin-out from the Adapt Research Ireland Centre for AI-Driven Digital Content Technology
We safeguard people, resources, and networks. For investigative intelligence on their data, Siren offers the…
Lette AI is developing an AI solution for property management, designed to assist real estate funds and…
Jentic Technology creates an integration layer for AI that allows developers to link agents to the global…
In 2017, Deciphex was established with the goal of using AI technology in digital pathology to enhance…
Brands and retailers are making crucial decisions regarding their stores and products every day, but often…
Biologit Funding FAQs
What does Biologit do?
Our company is in its infancy and focuses on utilizing artificial intelligence to address the challenges that come with clinical safety and pharmacovigilance. Our goal is to streamline the identification of negative drug reactions from drug development to post-market and enhance patient safety. The inaugural product we are creating is directed towards Medical Literature Monitoring (MLM), which will give medical product license holders, sponsors, patients, healthcare professionals, and scientists reliable data pertaining to the safety, effectiveness, and quality of medicinal products.
How much funding has Biologit raised?
Biologit has raised $3.2M across 2 rounds on record. The most recent is a Seed of $2.1M announced in Mar 2023.
When did Biologit last raise funding?
Biologit's most recent funding round on record is a Seed of $2.1M, announced in Mar 2023.
Who is the CEO of Biologit?
Nicole Baker is listed as CEO at Biologit.
Where is Biologit headquartered?
Biologit is based in Dublin, Ireland.
How many employees does Biologit have?
Biologit is in the 1-10 employee band.
How does Biologit's funding compare to other Artificial Intelligence startups?
Biologit's latest round of $2.1M is below the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Biologit Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biologit is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.